When you partner with Imagia Canexia Health Clinical Services, we help you implement a complete end-to-end solution, from sample accessioning to clinical report generation.
Our experienced team guides you through each step of the process, from assay development, validation, and service introduction to ongoing marketing and support.
Trust Imagia Canexia Health to help you rapidly implement assays, enabling precision oncology right from your lab.
Imagia Canexia Health’s complete implementation workflow empowers clinical labs to deploy cancer genomic testing from within their own facilities.
We’re here to support you, every step of the way. Joining our partner network means:
Your dedicated Imagia Canexia Health alliance manager helps guide your organization to success and remains your ongoing contact for support and maintenance throughout the partnership. Our streamlined process allows you to generate a rapid return on your organization’s investment.
January 20, 2021
This technical note describes the NGS assays developed by Canexia Health for somatic testing of adult solid tumors and how they are made available through local laboratories via our proprietary technology transfer model.
November 18, 2020
Precision oncology is experiencing immense movement, with a significant increase in the types of available molecular tests, increased reimbursement and coverage for tissue and liquid biopsy, and an increase in approved targeted therapies.